SCA
PFE icon

Salient Capital Advisors’s Pfizer PFE Stock Holding History

Salient Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-61,260
Closed -$1.95M – 151
2017
Q2 		$1.95M Sell
61,260
-18,640
-23% -$588K 0.04% 102
2017
Q1 		$2.59M Sell
79,900
-10,086
-11% -$318K 0.05% 96
2016
Q4 		$2.77M Sell
89,986
-703
-0.8% -$21.5K 0.05% 88
2016
Q3 		$2.91M Sell
90,689
-18,849
-17% -$630K 0.06% 85
2016
Q2 		$3.66M Hold
109,538
– – 0.08% 77
2016
Q1 		$3.08M Buy
109,538
+23,621
+27% +$675K 0.09% 81
2015
Q4 		$2.63M Buy
85,917
+7,236
+9% +$228K 0.07% 87
2015
Q3 		$2.35M Buy
78,681
+21,350
+37% +$685K 0.06% 92
2015
Q2 		$1.82M Buy
57,331
+3,172
+6% +$103K 0.03% 115
2015
Q1 		$1.79M Buy
54,159
+6,282
+13% +$200K 0.03% 107
2014
Q4 		$1.42M Buy
47,877
+4,268
+10% +$122K 0.03% 133
2014
Q3 		$1.22M Sell
43,609
-5,649
-11% -$159K 0.02% 143
2014
Q2 		$1.39M Sell
49,258
-14,793
-23% -$422K 0.03% 123
2014
Q1 		$1.95M Sell
64,051
-4,646
-7% -$139K 0.05% 99
2013
Q4 		$2M Buy
68,697
+833
+1% +$24.2K 0.06% 90
2013
Q3 		$1.85M Buy
67,864
+2,705
+4% +$73.6K 0.08% 81
2013
Q2 		$1.73M Buy
+65,159
New +$1.8M 0.08% 82

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Salient Capital Advisors's PFE Position: Q3 2017 in Review

Salient Capital Advisors sold out of Pfizer (PFE) in Q3 2017, closing a stake of 61,260 shares — an estimated $1.95M sold.

Salient Capital Advisors first reported a position in PFE in Q2 2013 and held it in 17 quarters. The position peaked at $3.66M in Q2 2016. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Salient Capital Advisors reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 61,260 Pfizer shares in Q3 2017, an estimated $1.95M.
  • Salient Capital Advisors first reported a position in Pfizer in Q2 2013 and held it in 17 quarters.
  • Salient Capital Advisors's Pfizer position peaked at $3.66M in Q2 2016.
  • 2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.